Literature DB >> 23808251

[Sugammadex use experience in pediatric oncology].

N V Matinyan, A I Saltanov, A A Mareeva.   

Abstract

Sugamnmadex is a new type agent for reversal of neuromuscular blockade in any stage. There are foreign and home sugammadex use studies; however the information of sugammadex use in Pediatric patients is not enough. The article deals with study results of sugammadex use in Pediatric surgical oncology for the reversal of neuromuscular blockade by the agent rocuronium. 42 Pediatric patients in age from 2 to 17 years after elective oncology surgeries were recruited in the study. The speed and entirety of myorelaxation shifting as an evidence of sugammadex effectiveness were assessed by the accelerometer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23808251

Source DB:  PubMed          Journal:  Anesteziol Reanimatol        ISSN: 0201-7563


  2 in total

1.  Sugammadex for reversal of rocuronium-induced neuromuscular blockade in pediatric patients: A systematic review and meta-analysis.

Authors:  Young Ju Won; Byung Gun Lim; Dong Kyu Lee; Heezoo Kim; Myoung Hoon Kong; Il Ok Lee
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

2.  The efficacy and safety of sugammadex for reversing postoperative residual neuromuscular blockade in pediatric patients: A systematic review.

Authors:  Guangyu Liu; Rui Wang; Yanhong Yan; Long Fan; Jixiu Xue; Tianlong Wang
Journal:  Sci Rep       Date:  2017-07-18       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.